Patents by Inventor Genadiy Kalayanov

Genadiy Kalayanov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HCV POLYMERASE INHIBITORS
    Publication number: 20190085010
    Abstract: The invention provides compounds of the formula: wherein B is a nucleobase selected from the groups (a) to (d): and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.
    Type: Application
    Filed: October 22, 2018
    Publication date: March 21, 2019
    Inventors: Genadiy KALAYANOV, Staffan TORSSELL, Horst WAHLING
  • HCV polymerase inhibitors
    Patent number: 10106571
    Abstract: The invention provides compounds of the formula: wherein B is a nucleobase selected from the groups (a) to (d): and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.
    Type: Grant
    Filed: November 27, 2017
    Date of Patent: October 23, 2018
    Assignee: MEDIVIR AB
    Inventors: Genadiy Kalayanov, Staffan Torssell, Horst Wahling
  • HCV POLYMERASE INHIBITORS
    Publication number: 20180105549
    Abstract: The invention provides compounds of the formula: wherein B is a nucleobase selected from the groups (a) to (d): and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.
    Type: Application
    Filed: November 27, 2017
    Publication date: April 19, 2018
    Inventors: Genadiy KALAYANOV, Staffan TORSSELL, Horst WAHLING
  • HCV polymerase inhibitors
    Patent number: 9828408
    Abstract: The invention provides compounds of the formula: wherein B is a nucleobase selected from the groups (a) to (d): and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: November 28, 2017
    Assignee: MEDIVIR AB
    Inventors: Genadiy Kalayanov, Staffan Torssell, Horst Wahling
  • HCV POLYMERASE INHIBITORS
    Publication number: 20170107244
    Abstract: The invention provides compounds of the formula: wherein B is a nucleobase selected from the groups (a) to (d): and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.
    Type: Application
    Filed: November 23, 2016
    Publication date: April 20, 2017
    Inventors: Genadiy KALAYANOV, Staffan TORSSELL, Horst WAHLING
  • HCV polymerase inhibitors
    Patent number: 9540411
    Abstract: The invention provides compounds of the formula: wherein B is a nucleobase selected from the groups (a) to (d): and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.
    Type: Grant
    Filed: July 14, 2016
    Date of Patent: January 10, 2017
    Assignee: MEDIVIR AB
    Inventors: Genadiy Kalayanov, Staffan Torssell, Horst Wahling
  • HCV POLYMERASE INHIBITORS
    Publication number: 20160340380
    Abstract: The invention provides compounds of the formula: wherein B is a nucleobase selected from the groups (a) to (d): and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.
    Type: Application
    Filed: July 14, 2016
    Publication date: November 24, 2016
    Inventors: Genadiy KALAYANOV, Staffan TORSSELL, Horst WAHLING
  • HCV polymerase inhibitors
    Patent number: 9481703
    Abstract: The invention provides compounds of the formula: wherein B is a nucleobase selected from the groups (a) to (d): and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.
    Type: Grant
    Filed: February 27, 2015
    Date of Patent: November 1, 2016
    Assignee: MEDIVIR AB
    Inventors: Genadiy Kalayanov, Staffan Torssell, Horst Wahling
  • HCV POLYMERASE INHIBITORS
    Publication number: 20160271160
    Abstract: The invention provides compounds of the formula: wherein B is a nucleobase selected from the groups (a) to (d): and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.
    Type: Application
    Filed: October 16, 2014
    Publication date: September 22, 2016
    Inventors: Genadiy KALAYANOV, Pedro PINHO, Hans WESTERLIND, Daniel WIKTELIUS, Horst WAHLING
  • HCV POLYMERASE INHIBITORS
    Publication number: 20150175648
    Abstract: The invention provides compounds of the formula: wherein B is a nucleobase selected from the groups (a) to (d): and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.
    Type: Application
    Filed: February 27, 2015
    Publication date: June 25, 2015
    Inventors: Genadiy KALAYANOV, Staffan TORSSELL, Horst WAHLING
  • 5-amino-4-hydroxypentoyl amides
    Patent number: 8592429
    Abstract: HIV inhibitors of formula (I) wherein R1 is halo, C1-4 alkoxy, trifluoromethoxy; R2 is a group of formula (A); R3 is a group of formula (B); R4 is a group of formula (C); n is 0 or 1; A is CH or N; R5 and R6 are hydrogen, C1-4 allyl, halo; R7 and R8 are C1-4 allyl or C1-4 alkoxy-C1-4 alkyl; R9 is C1-4 allyl, cyclopropyl, trifluoromethyl, C1-4 alkoxy, or dimethylamino; R10 is hydrogen, C1-4 alkyl, cyclopropyl, trifluoromethyl, C1-4 alkoxy, or dimethylamino; pharmaceutically acceptable addition salts and solvates thereof; pharmaceutical compositions containing these compounds as active ingredient and processes for preparing said compounds.
    Type: Grant
    Filed: December 10, 2010
    Date of Patent: November 26, 2013
    Assignee: Janssen R&D Ireland
    Inventors: Genadiy Kalayanov, Bart Rudolf Romanie Kesteleyn, Kevin Parkes, Bengt Bertil Samuelsson, Wim Bert Griet Schepens, Johannes Wilhelmus J. Thuring, Hans Kristian Wallberg, Jörg Kurt Wegner
  • 5-AMINO-4-HYDROXYPENTOYL AMIDES
    Publication number: 20120295920
    Abstract: HIV inhibitors of formula wherein R1 is halo, C1-4alkoxy, trifluoromethoxy; n is 0 or 1; A is CH or N; R5 and R6 are hydrogen, C1-4alkyl, halo; R7 and R8 are C1-4alkyl or C1-4alkoxyC1-4alkyl; R9 is C1-4alkyl, cyclopropyl, trifluoromethyl, C1-4alkoxy, or dimethylamino; R10 is hydrogen, C1-4alkyl, cyclopropyl, trifluoromethyl, C1-4alkoxy, or dimethylamino; pharmaceutically acceptable addition salts and solvates thereof; pharmaceutical compositions containing these compounds as active ingredient and processes for preparing said compounds.
    Type: Application
    Filed: December 10, 2010
    Publication date: November 22, 2012
    Inventors: Genadiy Kalayanov, Bart Rudolf Romanie Kesteleyn, Kevin Parkes, Bengt Bertil Samuelsson, Wim Bert Griet Schepens, Johannes Wilhelmus J. Thuring, Hans Kristian Wallberg, Jörg Kurt Wegner